Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
. 2020 Oct 31;38:100804. doi: 10.1016/j.nmni.2020.100804

Draft genome sequence of a multidrug-resistant emerging pathogenic isolate of Vibrio alginolyticus from the Red Sea

M Yasir 1,2,, R Ullah 1, F Bibi 1,2, S Bahadar Khan 3, AA Al-Sofyani 4, U Stingl 5, EI Azhar 1,2
PMCID: PMC7683337  PMID: 33294196

Abstract

The marine ecosystem is a growing reservoir of antimicrobial-resistant bacteria, and thus an emerging risk to human health. In this study, we report the first draft genome sequence of multidrug-resistant Vibrio alginolyticus strain OS1T-47, isolated from an offshore site in the Red Sea. The draft genome of V. alginolyticus OS1T-47 is 5 157 150 bp in length and has DNA G + C content of 44.83%. Strain OS1T-47 possesses 22 antimicrobial resistance genes, including those associated with multidrug-resistant efflux pumps.

Keywords: β-lactamase, genome, multidrug-resistance, Red sea, Vibrio alginolyticus


Vibrio alginolyticus is a Gram-negative halophilic bacterium commonly found in the marine environment. It is pathogenic in sea animals, and causes wound and ear infections in humans [1,2]. In immunocompromised patients, it can develop into necrotizing soft-tissue infections, and bacteraemia that could lead to septic shock [2]. Antimicrobial resistance in V. alginolyticus has increased in the last decade, representing a risk to human health and food security [2].

The sediment sample was collected from a relatively pristine offshore site (22°08′50.6″ N, 38°58′35.6″ E) from a depth of 9 m, as described previously [3]. Strain OS1T-47 of V. alginolyticus was isolated following serial dilution using marine agar medium (HiMedia, Mumbai, India) supplemented with 66% sterilized Red Sea water [3]. The media plates were incubated at 28°C for 72 hours, then colonies were sub-cultured to obtain pure isolates. The taxonomic classification of the strain was performed through comparative analyses of the 16S rRNA gene sequence and genome assembly using the EzBioCloud database (https://www.ezbiocloud.net) and SpeciesFinder 2.0 (https://cge.cbs.dtu.dk/services/SpeciesFinder/), respectively. Antimicrobial susceptibility was measured using the agar dilution method [3]. A paired-end library was prepared from the genomic DNA, and sequencing was performed using a V3 kit on a MiSeq platform (Illumina, Inc., San Diego, CA, USA), as described previously [4]. De novo assembly of the OS1T-47 genome was prepared using a SPAdes 3.9 algorithm from high-quality sequence reads. Annotation of the OS1T-47 genome was performed using PATRIC, a bacterial bioinformatics resource centre (https://www.patricbrc.org/) and Rapid Annotation using Subsystem Technology (RAST; http://rast.theseed.org/FIG/rast.cgi). Antimicrobial-resistance genes were identified using the Comprehensive Antibiotic Resistance Database (https://card.mcmaster.ca/analyze/rgi), ResFinder 3.1, RAST and PATRIC. The sequence reads were deposited into the European Nucleotide Archive (https://www.ebi.ac.uk/ena) under Accession number SAMEA6169146.

The draft genome of V. alginolyticus OS1T-47 is 5 157 150 bp long and has a DNA G + C content of 44.83%. A total of 4818 coding sequences were identified in the genome, consisting of 3787 proteins with functional assignments and 1031 hypothetical proteins (Table 1). Moreover, 142 RNA genes were detected, consisting of 131 transfer RNA and 11 ribosomal RNA genes. Strain OS1T-47 was phenotypically resistant to ampicillin, cefepime and tetracycline, but was susceptible to co-amoxiclav, cefotaxime, meropenem, streptomycin, ciprofloxacin and azithromycin. Also, the US CDC show that V. alginolyticus isolates are mainly resistant to ampicillin and cephem antibiotics [2,5]. Annotation revealed several antimicrobial resistance genes linked to fluoroquinolones (parC, parE, gyrA and gyrB), tetracycline (tet34 and tet35), elfamycin (EF-Tu) and β-lactamase (blaAmpC and blaCARB-42) (Table 1). It identified multidrug-resistant efflux pumps and genes potentially providing resistance to the heavy metals copper, cobalt, zinc, cadmium and arsenic. Moreover, several multidrug-resistance-associated genes, such as mdtA, mdtB, mdtE, mdtG, mdtL, mdtN, mexA, mexB, norm, marA and marR, were specifically found in the OS1T-47 in common with the 37 public genomes, using the application Compare Genomes from Pangenome in the KBase platform (http://www.kbase.us/). The isolate is predicted to be a human pathogen with a probability of 0.65, and 54 families matched with pathogenic families using the PathogenFinder 1.1 tool (https://cge.cbs.dtu.dk/services/PathogenFinder/).

Table 1.

Genome features, and antimicrobial resistance genes found in the draft genome of Vibrio alginolyticus strain OS1T-47

Genome features Attribute Number
DNA G + C content 44.83%
Draft genome length 5 157 150 bp
Coding region 4818
Transfer RNA 131
Ribosomal RNA 11
Hypothetical proteins 1031
Proteins with functional assignments 3787
Proteins with EC number assignments 1113
Proteins with GO assignments 932

Proteins with Pathway assignments
816
Antimicrobial resistance genes

Antibiotic class
Attribute
Genes
Multidrug-resistance RND efflux pump cmeA
RND efflux pump cmeB
RND efflux pump adeF
MATE ydhE/norM
RND efflux pump crp
MFS efflux pump mdtL
RND efflux pump tolC
RND efflux pump cpxR
Transcriptional regulator ompR
RND efflux pump acrB
ABC efflux pump macB
β-lactam Class C β-lactamase blaAmpC
CARB β-lactamase blaCARB-42
Peptidoglycan DD-transpeptidase mrdA
Penicillin-binding protein pbp1a
Fluoroquinolone DNA topoisomerase IV parC
DNA topoisomerase IV parE
DNA gyrase gyrA
DNA gyrase gyrB
Elfamycin Elongation factor EF-Tu
Tetracycline Tetracycline efflux pump tet35
Tetracycline inactivation enzyme tet34
Peptide antibiotics Phosphoethanolamine transferase ugd

In conclusion, we found that the genome of OS1T-47 carries clinically significant genes associated with pathogenicity and antimicrobial resistance. The possibility of dissemination of these genes in marine environments is considered to be a risk to seafood safety and could impact human health.

Conflict of interest

The authors have declared that there are no conflicts of interest in relation to this article.

Acknowledgement

This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, the Kingdom of Saudi Arabia (award number 12-BIO3090-03).

References

  • 1.Zheng Z., Li R., Wong M.H., Chan E.W., Xia X., Chen S. First detection of a blaCTX-M-15-carrying plasmid in Vibrio alginolyticus. J Glob Antimicrob Resist. 2018;13:206–208. doi: 10.1016/j.jgar.2018.04.007. [DOI] [PubMed] [Google Scholar]
  • 2.Jacobs Slifka K.M., Newton A.E., Mahon B.E. Vibrio alginolyticus infections in the USA, 1988–2012. Epidemiol Infect. 2017;145:1491–1499. doi: 10.1017/S0950268817000140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ullah R., Yasir M., Bibi F., Abujamel T.S., Hashem A.M., Sohrab S.S. Taxonomic diversity of antimicrobial-resistant bacteria and genes in the Red Sea coast. Sci Total Environ. 2019;677:474–483. doi: 10.1016/j.scitotenv.2019.04.283. [DOI] [PubMed] [Google Scholar]
  • 4.Farman M., Yasir M., Al-Hindi R.R., Farraj S.A., Jiman-Fatani A.A., Alawi M. Genomic analysis of multidrug-resistant clinical Enterococcus faecalis isolates for antimicrobial resistance genes and virulence factors from the western region of Saudi Arabia. Antimicrob Resist Infect Contr. 2019;8:55. doi: 10.1186/s13756-019-0508-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Centers for Disease Control and Prevention (CDC) US Department of Health and Human Services; Atlanta, GA: 2012. National antimicrobial resistance monitoring system: enteric bacteria; human isolates final report.https://www.cdc.gov/narms/pdf/2012-annual-report-narms-508c.pdf Available at: [Google Scholar]

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES